David Urso

David Urso

Chief Executive Officer chez MEI PHARMA, INC.

Fortune : 9 856 $ au 31/03/2024

60 ans
Health Technology
Consumer Services
Commercial Services

Profil

David M.
Urso
was the founder of Tioga Pharmaceuticals, Inc. (founded in 2005) where he held the title of COO, Director & General Counsel from 2013 to 2014.
He is currently the President, Chief Executive Officer & Director at MEI Pharma, Inc. (since 2014).
In his former positions, he worked as the Director-Corporate Development & Legal Affairs at DNA Sciences, Inc. from 2000 to 2002, and as an Attorney at Cooley Godward LLP from 1997 to 2000 and at Wilson Sonsini Goodrich & Rosati PC from 1995 to 1997.
He also worked as a Scientist at GlaxoSmithKline LLC and Perelman School of Medicine.
Mr. Urso received his undergraduate degree from The Reed Institute and his graduate degree from Harvard Law School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/10/2023 2 464 ( 0,04% ) 9 856 $ 31/03/2024

Postes actifs de David Urso

SociétésPosteDébut
MEI PHARMA, INC. Chief Executive Officer 02/06/2023
Tous les postes actifs de David Urso

Anciens postes connus de David Urso

SociétésPosteFin
Founder 01/04/2014
General Counsel 01/01/2002
General Counsel 01/01/2000
General Counsel 01/01/1997
Corporate Officer/Principal -
Voir l'expérience en détail de David Urso

Formation de David Urso

The Reed Institute Undergraduate Degree
Harvard Law School Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de David Urso

Relations

83

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
MEI PHARMA, INC.

Health Technology

Entreprise privées5

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. David Urso